Fluad
Product Images NDC 70461-025

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluad (NDC 70461-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – 0.5 mL Carton Label (Flu2e 0022 01)

Packaging label for FLUAD Influenza Vaccine, Adjuvanted, 15 mcg per 0.5 mL pre-filled syringes. The label indicates it is the 2026-2027 formula for adults 65 years of age and older. The package contains ten single-dose syringes for intramuscular use. Manufactured by Seqirus Inc. The label includes dosing and storage instructions, influenza strain information, and a barcode.*

FDA Label Image

Principal Display Panel – 0.5 mL Syringe Label (Flu2e 0022 02)

Label for FLUAD Influenza Vaccine, Adjuvanted 2026 - 2027 Formula, showing a 0.5 mL dose for intramuscular use. The label indicates the vaccine is for adults 65 years and older, manufactured by Seqirus Inc. It includes the US license number 2049 and NDC 70461-026-04 with space for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.